TrialClinical pharmacology in drug development2022

Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant.

Timothy Tyler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.